Value of MRI in Congenital Heart Disease

Sponsor
Assiut University
Study ID
NCT06752187
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Congenital Heart Disease

Eligibility Criteria

Sex
ALL
Age
0 Years - 18 Years
Healthy Volunteers
Not accepted

Study Details

Congenital heart disease (CHD) is the most prevalent congenital anomaly and a major cause of infant morbidity and mortality. It encompasses various cardiac chamber anomalies. CHD diagnosis relied on clinical information from auscultation and heart sounds, with X-rays providing indirect information. Since the 1970s, echocardiography has become the primary diagnostic tool due to its direct, safe, and portable nature, capable of defining anatomy and estimating hemodynamics. However, echocardiography has limitations, While CT provides valuable anatomical details, it lacks hemodynamic information and involves ionizing radiation. MRI, on the other hand, excels in both anatomical and functional analysis, offering detailed hemodynamic evaluations of blood flow through valves, great vessels, and septal defects.

Key Dates

First listed
Dec 30, 2024
Start date
Jan 31, 2025
Status verified
Dec 2024
Primary completion
Jan 31, 2026
Completion
Feb 28, 2026

Study Design

Enrollment
55 participants (estimated)

Primary Outcome Measure

Evaluation of hemodynamics in congenital heart disease [ Time Frame: Baseline ]

Related Studies